Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice-Reference-Cited by-同舟云学术

Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice

Published:2020-06 Issue: Volume:17 Page:418-428
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Gallinaro Alessandra,Borghi Martina,Pirillo Maria Franca,Cecchetti Serena,Bona Roberta,Canitano Andrea,Michelini Zuleika,Di Virgilio Antonio,Olvera Alex,Brander Christian,Negri Donatella,Cara Andrea

Funder

National Institute of Allergy and Infectious Diseases

Italian Ministry of Health Ricerca Finalizzata

European Union’s Horizon 2020

European Union’s Seventh Programme for Research, Technological Development and Demonstration

NIH AIDS Reagent Program

AIDS Program

NIAID

NIH

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference66 articles.

1. Toward integrase defective lentiviral vectors for genetic immunization;Negri;Curr. HIV Res.,2010

2. Integration-deficient lentiviral vectors: a slow coming of age;Wanisch;Mol. Ther.,2009

3. Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity;Negri;Expert Opin. Biol. Ther.,2011

4. Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells;Negri;Hum. Gene Ther.,2010

5. Self-inactivating lentiviral vectors with U3 and U5 modifications;Iwakuma;Virology,1999

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STANDARDISED FLOW CYTOMETRIC PROCEDURE FOR DEEP CHARACTERIZATION OF NANOPARTICLES;2024-07-19

2. Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2;iScience;2024-05

3. Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels;Vaccines;2023-10-30

4. The use of viral vectors in vaccine development;npj Vaccines;2022-07-04

5. Prospects of viral vector-mediated delivery of sequences encoding anti-HBV designer endonucleases;Gene Therapy;2022-05-24